|
1
|
Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement.
|
Leuk Lymphoma
|
2011
|
1.49
|
|
2
|
Combined measurement of plasma cell proliferative and apoptotic index in multiple myeloma defines patients with good and poor prognosis.
|
Leuk Res
|
2010
|
1.45
|
|
3
|
Comparison of imaging methods in POEMS syndrome.
|
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
|
2012
|
0.84
|
|
4
|
Prognostic value of hepatocyte growth factor, syndecan-1, and osteopontin in multiple myeloma and monoclonal gammopathy of undetermined significance.
|
ScientificWorldJournal
|
2012
|
0.81
|
|
5
|
The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
|
Haematologica
|
2005
|
0.80
|
|
6
|
Results of therapy and changing prognosis of multiple myeloma during the last 40 years in the region of North and Middle Moravia: group of 562 patients.
|
Hematol J
|
2003
|
0.77
|
|
7
|
10 years of experience with thalidomide in multiple myeloma patients: report of the Czech Myeloma Group.
|
Leuk Res
|
2013
|
0.77
|
|
8
|
Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.
|
Hematol J
|
2005
|
0.76
|
|
9
|
The correlation of serum immunoglobulin free light chain levels and selected biological markers in multiple myeloma.
|
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
|
2008
|
0.76
|
|
10
|
Monitoring of plasma cell proliferative and apoptotic indices in the course of multiple myeloma.
|
Leuk Lymphoma
|
2009
|
0.75
|
|
11
|
Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multiple myeloma patients.
|
Br J Haematol
|
2012
|
0.75
|
|
12
|
The relationship between some soluble osteogenic markers, angiogenic cytokines/other biological parameters and the stages of multiple myeloma evaluated according to the Durie-Salmon and International Prognostic Index stratification systems.
|
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
|
2009
|
0.75
|
|
13
|
Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
|
Nucl Med Rev Cent East Eur
|
2008
|
0.75
|
|
14
|
Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomib.
|
Eur J Haematol
|
2009
|
0.75
|
|
15
|
Unusual manifestation of multiple myeloma: focal affection of central nervous system in a patient with chronic lymphocytic leukaemia.
|
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
|
2009
|
0.75
|